Hypoalbuminemia in Critically Sick Children
ConditionHypoalbuminemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorAssiut University
About this trial
The primary outcome in this Hospital-based study is to correlate the significance of hypoalbuminemia with different prognosis and outcome of different pediatric diseases.
The secondary outcomes of this study are i) to investigate the frequency of occurrence of hypoalbuminemia ii) to evaluate whether hypoalbuminemia on admission is a marker of adverse outcome in this population iii) whether correction of albumin by Human Albumin infusion or FFP helps in decreasing the length of stay in pediatric care unit, morbidity (e.g., duration of ventilator use) or mortality of the sick child.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with an albumin level of less than 3.4 g/dL for patients 7 months or older and less than 2.5 g/dL for patients younger than 7 months.
Patients with Severe sepsis, Respiratory diseases, Neurological diseases, Cardiac diseases, Blood diseases and gastrointestinal diseases with low albumin level .
Disqualifiers
Immune deficiency patients
Malabsorption syndrome patients
Celiac disease patients
Protein loosing enteropathy patients
Trial population
critically sick children with hypoalbuminemia
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
blood sampling
Other interventionAlbumin level in blood
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
to correlate the significance of hypoalbuminemia with different prognosis and outcome of different pediatric diseases. 5
To evaluate whether hypoalbuminemia is a predictor of adverse outcome in different disease
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: